Kureha (JP:4023)
:4023
Want to see JP:4023 full AI Analyst Report?
Top Page
Kureha
(4023)
Select Model
Select Model
Rating:60Neutral
Price Target:
¥3,843.00
▼(-7.06% Downside)
Action:ReiteratedDate:02/11/26
The score is held back primarily by weak cash generation (negative TTM free cash flow) alongside higher leverage and modest ROE, despite stable profitability. Technicals are supportive with a strong uptrend, but overbought signals add near-term risk. Valuation is reasonable with a supportive dividend yield.
Positive Factors
Diversified specialty portfolio
Kureha's multi-segment business (specialty resins, functional chemicals, plastics, agrochemicals) and explicit R&D focus support durable revenue streams and product differentiation. Long-term supply relationships and specialized plants create entry barriers and stabilize demand across cycles, aiding medium-term resilience.
Negative Factors
Negative free cash flow
Persistent negative free cash flow means reported earnings are not converting into spendable cash after investments. This reduces financial flexibility, forces reliance on external financing or asset sales, and constrains sustainable dividend growth and organic reinvestment over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified specialty portfolio
Kureha's multi-segment business (specialty resins, functional chemicals, plastics, agrochemicals) and explicit R&D focus support durable revenue streams and product differentiation. Long-term supply relationships and specialized plants create entry barriers and stabilize demand across cycles, aiding medium-term resilience.
Read all positive factors
Kureha (4023) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥139.86B
Dividend Yield3.76%
Average Volume (3M)409.12K
Price to Earnings (P/E)10.0
Beta (1Y)0.65
Revenue Growth-5.60%
EPS Growth75.36%
CountryJP
Employees4,217
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)253.23
Shares Outstanding49,942,223
10 Day Avg. Volume239,800
30 Day Avg. Volume409,116
Financial Highlights & Ratios
PEG Ratio-1.37
Price to Book (P/B)0.69
Price to Sales (P/S)0.89
P/FCF Ratio-10.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,453.33Price Target Upside7.70% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)275.64
Revenue Forecast (FY)¥172.90B
Kureha Business Overview & Revenue Model
Company Description
Kureha Corporation manufactures and sells functional materials, specialty chemicals, and plastics in Japan and internationally. It operates through four segments: Advanced Materials, Specialty Chemicals, Specialty Plastics, Construction, and Other...
How the Company Makes Money
Kureha primarily makes money by manufacturing and selling chemical and materials products to industrial customers. Key revenue streams include: (1) Specialty resins and plastics: revenue from selling polymer-based materials (including packaging-re...
Kureha Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
56
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 157.77B | 162.01B | 177.97B | 191.28B | 168.34B | 144.57B |
| Gross Profit | 42.73B | 42.49B | 51.34B | 54.79B | 50.88B | 42.87B |
| EBITDA | 23.19B | 22.60B | 30.39B | 34.43B | 34.91B | 29.11B |
| Net Income | 9.94B | 7.80B | 9.73B | 16.87B | 14.16B | 13.49B |
Balance Sheet | ||||||
| Total Assets | 359.22B | 345.30B | 328.51B | 296.40B | 282.64B | 256.92B |
| Cash, Cash Equivalents and Short-Term Investments | 25.66B | 21.50B | 23.13B | 32.20B | 30.64B | 17.83B |
| Total Debt | 118.05B | 84.71B | 53.59B | 24.99B | 27.49B | 28.23B |
| Total Liabilities | 175.25B | 134.16B | 107.48B | 79.63B | 81.91B | 71.40B |
| Stockholders Equity | 182.15B | 209.37B | 219.26B | 215.20B | 199.22B | 183.83B |
Cash Flow | ||||||
| Free Cash Flow | -4.08B | -14.31B | -21.10B | 8.51B | 15.99B | 13.83B |
| Operating Cash Flow | 24.63B | 29.52B | 11.60B | 22.74B | 28.58B | 26.70B |
| Investing Cash Flow | -22.09B | -39.44B | -34.29B | -11.10B | -11.00B | -3.88B |
| Financing Cash Flow | -2.20B | 8.44B | 12.13B | -10.48B | -6.11B | -12.52B |
Kureha Technical Analysis
Negative
4135.00
Price Trends
4366.71
Negative
4186.31
Negative
3831.34
Positive
Market Momentum
-32.47
Negative
47.02
Neutral
70.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4023, the sentiment is Negative. The current price of 4135 is above the 20-day moving average (MA) of 4132.38, below the 50-day MA of 4366.71, and above the 200-day MA of 3831.34, indicating a neutral trend. The MACD of -32.47 indicates Negative momentum. The RSI at 47.02 is Neutral, neither overbought nor oversold. The STOCH value of 70.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4023.
Kureha Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥359.59B | 14.16 | 9.59% | 3.91% | 0.25% | 21.48% | |
78 Outperform | ¥175.98B | 22.82 | ― | 2.84% | 4.10% | 5.25% | |
76 Outperform | ¥446.20B | 17.67 | 6.52% | 1.82% | 2.84% | 65.28% | |
74 Outperform | ¥296.44B | 9.05 | 5.47% | 3.41% | 0.23% | -3.05% | |
72 Outperform | ¥1.93T | 18.54 | 11.98% | 1.54% | 1.41% | 0.76% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥139.86B | 9.97 | 4.24% | 3.76% | -5.60% | 75.36% |
* Basic Materials Sector Average
JP:4023
Kureha
3,660.00
1,269.62
53.11%
JP:4118
Kaneka
4,921.00
1,521.55
44.76%
JP:6988
Nitto Denko
2,995.00
416.71
16.16%
JP:4205
Zeon
1,882.50
540.65
40.29%
JP:4203
Sumitomo Bakelite Co., Ltd.
5,433.00
2,151.04
65.54%
JP:7970
Shin-Etsu Polymer Co., Ltd.
2,174.00
765.36
54.33%
Kureha Corporate Events
Kureha Takes ¥36.5 Billion Impairment, Cuts Forecast and Dividend on PVDF and Drug Weakness
Apr 30, 2026
Kureha Corporation will book significant impairment losses in FY2025 on manufacturing facilities for its PVDF battery materials and KREMEZIN drug due to slower EV demand in Europe and the U.S. and shrinking spherical activated carbon demand. The w...
Kureha to Grant Restricted Treasury Shares to Executives With Minimal Dilution
Apr 28, 2026
Kureha Corporation has approved the disposal of 3,006 shares of its treasury stock as restricted stock remuneration for five executive officers, with a disposal price of 3,890 yen per share and a total value of 11.69 million yen. The company noted...
Kureha Proposes Director Slate Emphasizing Governance Continuity and Oversight
Apr 28, 2026
Kureha Corporation has proposed a slate of seven directors for approval at its shareholders meeting scheduled for late June 2026, including the reappointment of Representative Director and Chairman Yutaka Kobayashi and Representative Director, Pre...
Kureha’s Top Shareholder Meiji Yasuda Trims Stake but Retains Leading Position
Apr 8, 2026
Kureha Corporation has announced a change in its major and principal shareholder after updating its shareholder register as of March 31, 2026. Life insurer Meiji Yasuda Life Insurance Company remains the largest shareholder, though its stake has d...
Kureha Lifts Profits on Lower Sales, Doubles Down on Shareholder Returns
Feb 9, 2026
Kureha reported nine-month revenue to December 31, 2025, of ¥117.8 billion, down 3.5% year on year, but operating profit jumped 27.5% to ¥13.3 billion and profit attributable to owners rose 26.4% to ¥10.2 billion, lifting earnings p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.